• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Rob Nolan Discusses Behavioral Foundations of eCounseling Programs

Video

The use of technology in behavioral interventions is exciting, but it is important to integrate the underlying principles of behavioral science when developing counseling interventions, explained Rob Nolan, PhD, CPsych, director of Cardiac eHealth at the Peter Munk Cardiac Centre and clinical psychologist and scientist at the Toronto General Research Institute, at the American College of Cardiology 66th Scientific Session, where he presented the results of the REACH eCounseling trial.

The use of technology in behavioral interventions is exciting, but it is important to integrate the underlying principles of behavioral science when developing counseling interventions, explained Rob Nolan, PhD, CPsych, director of Cardiac eHealth at the Peter Munk Cardiac Centre and clinical psychologist and scientist at the Toronto General Research Institute, at the American College of Cardiology 66th Scientific Session, where he presented the results of the REACH eCounseling trial.

Transcript (slightly modified)

How can clinicians get the most benefit out of new technologies like eCounseling?

I think what’s important for us is, when we were starting REACH, we saw that technology was certainly growing exponentially, right. There’s a lot of interest in using different types of technological supports, whether it’s text messaging, wearable devices to monitor our responses. I think all that is superb, but I think what worked in REACH was that we were able to extract the evidence-based components of the behavioral counseling models that have been shown to be effective in the past, and I think combining the two really optimizes our interventions.

I think without really having a specific model of behavioral counseling, the technology alone, I don’t think that typically will sustain the change. Also, the kinds of comparisons that we could make from trial to trial really will vary and we’ll have that ongoing problem of heterogeneity of treatment effects, because there won’t be any consistency. I think the counseling or clinically applied science is really important to integrate here for that reason.

Related Videos
Debra Boyer, MD, MHPE, ATSF.
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
ISPOR 2024 Recap
Screenshot of Stephen Freedland, MD, during a video interview
Phaedra Corso, PhD, associate vice president for research at Indiana University
William Padula, PhD, MSc, MS, assistant professor of pharmaceutical and health economics, University of California Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences
Screenshot of Angela Jia, MD, PhD, during a video interview
Nancy Dreyer, MPH, PhD, FISE, chief scientific advisor to Picnic Health
Screenshot of Alexander Kutikov, MD, during a video interview
Neil Goldfarb, CEO, Greater Philadelphia Business Coalition on Health
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.